To view this email as a web page, click here

Today's Rundown

Featured Story

New fair price for Gilead's remdesivir? Below $2,800 if dexamethasone lives up to its COVID-19 promise

Nearly two months ago, an influential drug cost watchdog pegged $4,460 as the fair price for Gilead Sciences’ authorized COVID-19 therapy remdesivir. But on coronavirus time, that's an eternity—and a lot has changed since then.

read more

Top Stories

How much will healthcare costs go up next year? It's anyone's guess, says PwC

Healthcare costs for employer-sponsored plans are likely to increase in 2021, but it remains unclear by how much due to massive changes prompted by the COVID-19 pandemic, a new report finds.

read more

U.K. launches new national COVID-19 test validation project

The U.K. government is launching a national research program, in collaboration with a number of universities, NHS trusts and medical research groups, to evaluate new coronavirus diagnostic tests and how well they perform in different settings.

read more

Here's a look at doctors' pre-COVID-19 net worth, including how much their houses cost

Doctors have taken a financial hit in the era of COVID-19. Here's a look at what many of them said before the pandemic about their financial picture, including how many have student loans, how large their homes and mortgages are and their estimated net worth.

read more

Fauci says government faces financial risk in race to find COVID-19 vaccine

Infectious disease expert Anthony Fauci told lawmakers that the federal government is only taking on financial risk in the race to develop a COVID-19 vaccine, and won't compromise on safety and effectiveness.

read more

Biopharma roundup: Dexamethasone could thwart remdesivir pricing plans; Greek researchers tap ancient med to treat novel virus

Dexamethasone's swift rise as a COVID-19 treatment could hurt remdesivir's final price tag, according to an updated ICER assessment published Wednesday. The U.K. is tapping universities, NHS trusts and researchers in a new COVID test validation effort. Plus, a Greek study showed an ancient drug could curb severe COVID-19.

read more

Healthcare roundup: HHS defends ending funding to 13 test sites

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

read more